Filing Details
- Accession Number:
- 0001140361-10-017715
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-27 13:00:00
- Reporting Period:
- 2010-04-23
- Filing Date:
- 2010-04-27
- Accepted Time:
- 2010-04-27 17:35:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1037760 | Cepheid | CPHD | Laboratory Analytical Instruments (3826) | 770441625 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1318763 | Robert Koska | C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089 | Svp Ww Commercial Ops | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-04-23 | 148,633 | $10.74 | 156,133 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-04-23 | 148,633 | $20.74 | 7,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-04-23 | 148,633 | $0.00 | 148,633 | $10.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-02-21 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 28, 2009.
- Includes 7,500 shares subject to a right of repurchase, which right lapses as to 50% of the shares on April 25, 2010 and April 25, 2011.
- 100% of the shares subject to the grant are vested and exercisable.
Billionaire Hedge Funds
